Series B is a person tracked in our intelligence system with 6 linked articles.
Valar Atomics raises a $1B Series B led by Sequoia to commercialize its 5MW Ward 250 microreactor, with NRC approval still pending and regulatory shifts from the U.S. DOE and federal agenda shaping the path.
Simile raises a $200M Series B at a $2B valuation just 5 months after a $100M Series A, with Greenoaks leading and investors including Index Ventures, CVS Health Ventures, and others; CVS is also a marquee customer for its synthetic-user product.
Corgi, an AI-powered insurtech, reportedly hit a $4B valuation after its fourth raise of the year, with earlier rounds valuing the company at $1.3B, $2.6B, and an undisclosed amount; it previously had a $40M annualized revenue run rate and now projects $450M by year-end amid vertical expansion.
Quaise Energy raises $134M in a first tranche of its Series B to push a 50MW “superhot” geothermal plant in Oregon (Project Obsidian), aiming for 2030 COD, with total funding at $230M and plans to secure ~$100M more in grants/debt and sign power deals, backed by Prelude Ventures and strategic investors including JERA and Idemitsu Kosan.
Unastella raises a $24M Series B (bringing total funding to $44M) to push its Una Express launch vehicles, with in-house design/manufacturing and a plan toward orbital launches, amid a regulatory landscape in Korea that funds space infrastructure and enables tech transfers.
XCENA raises $135M Series B at a $570M valuation to back memory-centric AI hardware (MX1) with mass production expected by late 2026 and revenue in 2027.
Subscribe for real-time person updates and unlimited access to our intelligence platform.